Treatment of Psychogenic Nonepileptic Seizures, 2022, Lopez & LaFrance

Andy

Retired committee member
Abstract

Purpose of Review
Psychogenic nonepileptic seizures (PNES) are the most common Functional Neurological Disorder/Conversion Disorder subtype. Significant advances have been made related to diagnosis, neurobiology, and treatment. In this review, we summarize updates in diagnosis and management over the past 3 years.

Recent Findings
Although evidence is mixed for the treatment of PNES, psychotherapeutic modalities remain a powerful instrument to empower patients and reduce seizures. A multidisciplinary, holistic approach is beneficial. While seizure freedom in all patients may not be the achieved endpoint in this chronic, paroxysmal disorder, quality of life can be improved with treatment. Additional treatment modalities and further research are needed for patients who are refractory to current treatment.

Summary
Evidence-based therapies exist for PNES, and recent findings represent an increased understanding of the clinical and neurophysiologic aspects of PNES.

Paywall, https://link.springer.com/article/10.1007/s11910-022-01209-3
 
psychotherapeutic modalities remain a powerful instrument to empower patients and reduce seizures
then
While seizure freedom in all patients may not be the achieved endpoint in this chronic, paroxysmal disorder, quality of life can be improved with treatment.

Translation
We know the 10 year CODES trial showed our therapies don't help with seizures but we still believe they are fantastic and don't want the funding to stop rolling in
 
Back
Top Bottom